# reload+after+2024-01-22 05:30:02.382560
address1§980 Great West Road
address2§Middlesex
city§Brentford
zip§TW8 9GS
country§United Kingdom
phone§44 20 8047 5000
website§https://www.gsk.com
industry§Drug Manufacturers—General
sector§Healthcare
longBusinessSummary§GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
fullTimeEmployees§69400
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Emma Natasha Walmsley', 'age': 53, 'title': 'CEO & Director', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 6090979, 'exercisedValue': 1480937, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Julie Belita Brown', 'age': 61, 'title': 'CFO & Executive Director', 'yearBorn': 1962, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Shobie  Ramakrishnan', 'title': 'Chief Digital & Technology Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Tony  Wood', 'title': 'Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sarah  Elton-Farr', 'title': 'Head of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. James  Ford', 'title': 'Senior VP & Group General Counsel of Legal & Compliance', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sally  Jackson', 'title': 'Senior Vice President of Global Communications & CEO Office', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David Simon Redfern BSc (Hons), CA', 'age': 57, 'title': 'President of Corporate Development', 'yearBorn': 1966, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Diana  Conrad', 'title': 'Chief People Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Philip C. Thomson', 'title': 'President of Global Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§10
boardRisk§8
compensationRisk§10
shareHolderRightsRisk§1
overallRisk§9
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
dividendRate§1.4
dividendYield§0.0358
exDividendDate§1700092800
payoutRatio§0.3845
fiveYearAvgDividendYield§5.06
beta§0.248
priceToSalesTrailing12Months§2.7207656
currency§USD
dateShortInterest§1702598400
forwardEps§3.92
pegRatio§2.08
exchange§NYQ
quoteType§EQUITY
shortName§GSK plc
longName§GSK plc
firstTradeDateEpochUtc§323101800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a7130272-5c50-3936-b6ce-1eb2c57020e3
gmtOffSetMilliseconds§-18000000
targetHighPrice§48.0
targetLowPrice§35.0
targetMeanPrice§42.25
targetMedianPrice§43.0
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§4
quickRatio§0.695
earningsGrowth§-0.866
grossMargins§0.72143996
ebitdaMargins§0.30979002
trailingPegRatio§1.0327
